Related Experiment Video
Updated: Jul 16, 2026

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 12, 2013
Thrombin inhibits migration of human hepatic myofibroblasts
Jennifer Gillibert-Duplantier1, Véronique Neaud, Jean-Frédéric Blanc
1INSERM U889, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. jean.rosenbaum@gref.u-bordeaux2.fr
Abstract:
Several lines of data recently pointed out a role of the serine proteinase thrombin in liver fibrogenesis, but its mechanism of action is unknown. The aim of this study was to evaluate the effect of thrombin on the migration of human liver myofibroblasts. We show here that thrombin inhibits both basal migration and platelet-derived growth factor (PDGF)-BB-induced migration of myofibroblasts. By using a thrombin antagonist, a protease-activated receptor (PAR)-1 mimetic peptide, and a PAR-1 antibody, we show that this effect is dependent on the catalytic activity of thrombin and on PAR-1 activation. Thrombin's effect on basal migration was dependent on cyclooxygenase 2 (COX-2) activation because it was blocked by the COX-2 inhibitors NS-398 and nimesulide, and pharmacological studies showed that it was relayed through prostaglandin E(2) and its EP(2) receptor. On the other hand, thrombin-induced inhibition of PDGF-BB-induced migration was not dependent on COX-2. We show that thrombin inhibits PDGF-induced Akt-1 phosphorylation. This effect was consecutive to inhibition of PDGF-beta receptor activation through active dephosphorylation. Thus thrombin, through two distinct mechanisms, inhibits both basal- and PDGF-BB-induced migration of human hepatic liver myofibroblasts. The fine tuning of myofibroblast migration may be one of the mechanisms used by thrombin to regulate liver fibrogenesis.
Insights
Thrombin, a key enzyme in liver fibrogenesis, inhibits human liver myofibroblast migration through two distinct pathways. This action, mediated by protease-activated receptor-1 (PAR-1), may regulate liver scarring.
Area of Science:
- Cell Biology
- Biochemistry
- Hepatology
Background:
- Emerging data suggest thrombin's involvement in liver fibrogenesis.
- The precise mechanism by which thrombin influences liver fibrosis remains unclear.
- Understanding thrombin's role in myofibroblast behavior is crucial for deciphering fibrogenesis.
Purpose of the Study:
- To investigate the effect of thrombin on human liver myofibroblast migration.
- To elucidate the molecular mechanisms underlying thrombin's action on myofibroblasts.
Main Methods:
- Assessed myofibroblast migration in response to thrombin.
- Utilized thrombin antagonists, PAR-1 mimetic peptides, and antibodies to probe receptor involvement.
- Investigated the roles of cyclooxygenase-2 (COX-2), prostaglandin E(2), and EP(2) receptors.
- Examined signaling pathways including Akt-1 phosphorylation and PDGF-beta receptor activation.
Main Results:
- Thrombin significantly inhibited both basal and PDGF-BB-induced myofibroblast migration.
- The inhibitory effect on basal migration was dependent on thrombin's catalytic activity, PAR-1 activation, COX-2, prostaglandin E(2), and EP(2) receptor signaling.
- Thrombin's inhibition of PDGF-BB-induced migration involved the suppression of PDGF-induced Akt-1 phosphorylation via dephosphorylation of the PDGF-beta receptor, independent of COX-2.
Conclusions:
- Thrombin exerts dual inhibitory effects on human liver myofibroblast migration.
- These mechanisms, involving PAR-1, COX-2/prostaglandin pathways, and PDGF receptor signaling, suggest thrombin's regulatory role in liver fibrogenesis.
- Modulation of myofibroblast migration by thrombin may be a key factor in controlling liver scarring progression.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Intracellular Signaling Affects Focal Adhesions
Some...
Cirrhosis II: Pathophysiology
Clot Retraction and Fibrinolysis
